CGTX
CGTX
NASDAQ · Pharmaceuticals

Cognition Therapeutics Inc

$0.99
+0.10 (+10.84%)
As of Aug 8, 2:15 AM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +3,033.3% upside
Low Target $22.83
Average Target $30.96
High Target $36.58
Current Price $0.99
Current
$0.99
Target
$30.96
$22.83 $30.96 avg $36.58
Scenario Analysis
Bear Case
$22.83
2,210.5%
Low target
Base Case
$30.96
+3,033.3%
Avg target
Bull Case
$36.58
+3,602.1%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$3.83
-74.2% from high
52-Week Low
$0.55
+79.6% from low
Target vs 52W High
$30.96
+708.4% vs high
Next Earnings Report
Aug 11, 2026
2d
until earnings
EPS Est: $-0.06
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +12.2%
RDY
Dr. Reddy's Laboratories
Sell 44 52% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +15.5%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +23.9%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +26.7%
BMY
Bristol-Myers Squibb Co
Hold 35 40% $174.50 +169.6%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -36.1%
ZTS
Zoetis Inc
Hold 24 54% $209.87 +188.8%